National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G03CC06	GYNOFLOR	B	Estriol - 0.03mg, Lactobacillus acidophillus - 10 MIU		Tablet	813,025 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 1,000mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 15mg/5ml	15mg/5ml	Liquid	258,018 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 50mg	50mg	Tablet	163,949 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml		Drops solution	950,097 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 100mg	100mg	Suppository	294,302 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml		Drops solution	950,097 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,482,387 L.L
J06BA02	GAMUNEX-C	BioHuman	Human normal immunoglobulin G - 10%	10%	Injectable solution	39,990,287 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 900IU/1.5ml	66mcg/1.5ml	Injectable solution	29,625,401 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 450IU/0.75ml	450IU/0.75ml	Injectable solution	14,813,959 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 300IU/0.5ml	300IU/0.5ml	Injectable solution	10,305,698 L.L
A10AE04	GLARTUS	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	1,346,530 L.L
H01AC01	GENOTROPIN	BioTech	Somatropin recombinant - 5.3mg/1.15ml	5.3mg/1.15ml	Injectable powder for solution+diluent	4,724,854 L.L
H01AC01	GENOTROPIN GOQUICK	BioTech	Somatropin recombinant - 12mg/ml	12mg/ml	Injectable powder for solution+diluent	25,170,264 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	314,437,416 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	L.L
H04AA01	GLUCAGEN	BioTech	Glucagon HCl - 1mg	1mg	Injectable powder for solution+diluent	1,343,444 L.L
N02BF02	GABRIKA 75	G	Pregabalin - 75mg	75mg	Capsule	793,507 L.L
N02BF02	GALICA 75	G	Pregabalin - 75mg	75mg	Capsule	338,648 L.L
A10BF01	GLUFIX	G	Acarbose - 50mg	50mg	Tablet	1,294,120 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 6g/20ml	30%	Injectable solution	5,157,668 L.L
N02BF02	GABRIKA 100	G	Pregabalin - 100mg	100mg	Capsule	798,626 L.L
N02BF02	GABRIKA 25	G	Pregabalin - 25mg	25mg	Capsule	560,062 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	38,254,090 L.L
N02BF02	GABRIKA 25	G	Pregabalin - 25mg	25mg	Capsule	341,720 L.L